Assignee
UNITY BIOTECHNOLOGY INC
US26 patents
Top patents by PatentIndex Score
US10195213B2Feb 5, 2019
Chemical entities that kill senescent cells for use in treating age-related disease
UNITY BIOTECHNOLOGY INC15 citations94
US10328073B2Jun 25, 2019
Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalmic disease by selectively removing senescent cells
UNITY BIOTECHNOLOGY INC9 citations92
US10130628B2Nov 20, 2018
Treatment of joint pain
UNITY BIOTECHNOLOGY INC6 citations91
US10517866B2Dec 31, 2019
Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (PI3K) inhibitor
UNITY BIOTECHNOLOGY INC5 citations83
US10478433B2Nov 19, 2019
Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss
UNITY BIOTECHNOLOGY INC4 citations83
US10981892B2Apr 20, 2021
Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
UNITY BIOTECHNOLOGY INC2 citations73
US10717722B2Jul 21, 2020
Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
UNITY BIOTECHNOLOGY INC2 citations73
US10519197B1Dec 31, 2019
Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
UNITY BIOTECHNOLOGY INC3 citations73
US10426788B2Oct 1, 2019
Chemical entities that kill senescent cells for use in treating age-related disease
UNITY BIOTECHNOLOGY INC2 citations73
US10279018B2May 7, 2019
Immunogenic compositions for inducing an immune response for elimination of senescent cells
UNITY BIOTECHNOLOGY INC3 citations71
US10550378B2Feb 4, 2020
Composition comprising a gene vector that selectively depletes P16 positive senescent cells
UNITY BIOTECHNOLOGY INC2 citations70
US10378002B2Aug 13, 2019
Replication conditional virus that specifically kills senescent cells
UNITY BIOTECHNOLOGY INC2 citations70
US11129838B2Sep 28, 2021
Methods of inhibiting pathological angiogenesis
UNITY BIOTECHNOLOGY INC2 citations68
US10588916B2Mar 17, 2020
Technology to inhibit vascular changes that lead to vision loss in the eye
UNITY BIOTECHNOLOGY INC2 citations68
US12221433B2Feb 11, 2025
Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
UNITY BIOTECHNOLOGY INC0 citations62
US11865123B2Jan 9, 2024
Methods of inhibiting pathological angiogenesis
UNITY BIOTECHNOLOGY INC0 citations57
US12195542B2Jan 14, 2025
Antibodies directed to Tie-2 and methods of use
UNITY BIOTECHNOLOGY INC1 citations52
US10689416B2Jun 23, 2020
Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
UNITY BIOTECHNOLOGY INC0 citations52
US11111259B2Sep 7, 2021
Acylsulfonamide derivatives for treating senescence-associated diseases and disorders
UNITY BIOTECHNOLOGY INC0 citations50
US10329279B2Jun 25, 2019
Chiral synthesis method for producing cis-imidazoline compounds for pharmaceutical use
UNITY BIOTECHNOLOGY INC0 citations50
US9988368B1Jun 5, 2018
Chiral synthesis method for producing cis-imidazoline compounds for pharmaceutical use
UNITY BIOTECHNOLOGY INC1 citations50
US11951115B2Apr 9, 2024
Methods of treating retinal vasculopathies
UNITY BIOTECHNOLOGY INC0 citations49
US10745429B2Aug 18, 2020
Phospholidines that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
UNITY BIOTECHNOLOGY INC0 citations41
US10703745B2Jul 7, 2020
Acyl phosphonamidates and acyl benzylamines that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
UNITY BIOTECHNOLOGY INC0 citations41
US10745445B2Aug 18, 2020
Conjugates that are configured for targeted delivery of therapeutic compounds to senescent cells
UNITY BIOTECHNOLOGY INC0 citations38
US9969776B2May 15, 2018
Drug conjugates for delivering compounds to senescent cells
UNITY BIOTECHNOLOGY INC1 citations38